Opdivo Qvantig is the first subcutaneously administered PD-1 inhibitor approved by the FDA. It is expected to be available in ...
One of this year's top articles on cost and coverage highlights that the average American can afford a maximum of $97 in ...
Of the top news articles, Vertex Pharmaceuticals' suzetrigine garnered much attention as it's a promising new class of pain ...
Take a look at the best performing print articles of 2024. This year's top article spotlights the surge of mRNA vaccines ...
Take a look at the best performing print articles of 2024. This year's top article spotlights the surge of mRNA vaccines ...
Historically, healthcare organizations have considered the contact center to be a cost center, a communications platform for ...
Anna Podolanczuk, M.D., M.S., discusses how key epidemiological trends in idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), including changes in incidence and prevalence, ...
The boxed warning follows a safety warning the FDA issued in September about the risk of liver injury from the use of Veozah ...
Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...
Some muscles are resistant to the loss of motor neurons seen in patients with spinal muscular atrophy, and new research has ...
Up to half of obstructive sleep apnea patients taking Zepbound had no symptoms after one year of treatment, averaging 25 ...
Gene therapies are revolutionizing treatment for hemophilia A and sickle cell disease; however, they are saddled with hefty ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback